Abstract
Testosterone deficiency in men is associated with increased atherosclerosis burden and increased cardiovascular risk. In male mice, testosterone deficiency induced by castration increases atherosclerosis as well as mature B cell numbers in spleen. As B cells are potentially pro-atherogenic, we hypothesized that there may be a link between these effects. To address whether mature B cell deficiency alter the atherogenic response to castration, we studied B cell-deficient μMT and genotype control male mice on an atherosclerosis-prone Apoe−/− background that were castrated or sham-operated pre-pubertally and fed a high-fat diet between 8 and 16 weeks of age to accelerate atherosclerosis development. Genotype did not affect the effects of castration on body weight or weights of fat depots and there were no differences in serum cholesterol levels across the four groups. Atherosclerosis assessed by quantification of lesion area in serial sections of the aortic root was significantly increased by castration and by the μMT mutation, with no significant interaction between genotype and surgery. In conclusion, castration evokes a similar atherogenic response in B cell-deficient μMT and control mice. These data suggest that atherogenesis following castration is unrelated to the effects of androgens on mature B cell numbers.
Similar content being viewed by others
Introduction
Testosterone is the most important sex hormone in men, with central roles in reproduction, behavior, and metabolism. Testosterone deficiency in men is associated with increased atherosclerosis burden as well as increased cardiovascular risk1,2. In accordance, androgen deprivation therapy, the foundation of treatment of advanced prostate cancer, also has been associated with increased risk of cardiovascular events3 and progress in the understanding of the mechanisms underlying castration-induced atherosclerosis will be of great clinical relevance. In line with clinical data, castration i.e., removal of the testes and thereby induction of testosterone deficiency in the male mouse, increases atherosclerosis in animal models4.
The immune system is an important player in atherogenesis; many classes of leukocytes mediate and/or modulate an immune reaction against lipid particles in the vascular wall, which is central to the pathogenesis of atherosclerosis5. B cells have been shown to have both pro- and anti-atherogenic properties, where both subset and context determine effects on atherogenesis6. The role of B cells in atherosclerosis is a highly active research area6. Testosterone has important immunological effects, including regulation of B cell homeostasis in both male mice and humans7,8. Castration of male mice increases the number of B cell precursors in the bone marrow as well as the number of mature B cells in spleen7,8,9. The castration-induced effects are mirrored by androgen receptor (AR) deficiency; AR-deficient mice show an increase in B lymphopoiesis from the pro-B cell stage in bone marrow through immature transitional B cells to mature B1 and B2 cells in spleen8,9.
As castration increases both atherosclerosis and B cell numbers, we hypothesized that there may be a link between these two effects. The aim of the present study was to evaluate a potential role of mature B cells in castration-induced atherogenesis. To address the question, we utilized μMT mice, which lack mature B cells due to a targeted disruption of one of the membrane exons of the immunoglobulin mu chain gene10. We crossed μMT mice with atherosclerosis-prone Apoe−/− mice and studied the atherogenic response to castration in male μMT and control mice.
Results
To add to our previous detailed investigation of B cell subsets in AR-deficient mice, which are testosterone- and AR-deficient from the embryonal stage and mirror the B cell as well as atherosclerosis phenotype of castrated mice4,8, we first asked whether these mice show altered levels of immunoglobulins that are implicated in atherogenesis11. Serum total and oxidized low-density lipoprotein (oxLDL)-specific immunoglobulin levels were quantified in male AR-deficient mice (Ary/-) and controls (Ary/+) on Apoe-/- background that had been fed high-fat diet between 8 and 16 weeks of age. Median [interquartile range] levels of total IgM (Ary/+ 1.00 [0.83–1.19] and Ary/- 0.73 [0.55–1.13] AU, p = 0.25) and IgG (Ary/+ 1.00 [0.91–1.12] and Ary/- 0.83 [0.76–1.00] AU, p = 0.27) as well as oxLDL-specific IgM (Ary/+ 1.00 [0.82–2.14] and Ary/- 0.76 [0.39–1.17] AU, p = 0.16) and oxLDL specific IgG (Ary/+ 1.00 [0.87–1.49] and Ary/- 1.30 [0.83–3.41] AU, p = 0.25) were all unchanged in these mice.
To address whether B cell deficiency alter the atherogenic response to castration in male mice, we studied μMT and genotype control mice on an atherosclerosis-prone Apoe-/- background that were castrated or sham-operated before puberty (at 3 weeks of age) and fed a high-fat diet between 8 and 16 weeks of age to accelerate atherosclerosis development. At 16 weeks of age, spleen weight was prominently affected by the genotype of the mice (− 75.8 ± 1.4% in μMT Sham vs. Control Sham and − 76.8 ± 2.0% in μMT ORX vs. Control ORX) and slightly increased by castration in control mice (+ 25.6 ± 7.1% in Control ORX vs. Control Sham) (Fig. 1a). The well-described effect of castration to increase thymus weight12 was similar in μMT (+ 28.4 ± 4.2% in μMT ORX vs. μMT Sham) and genotype control (+ 29.7 ± 5.6% in Control ORX vs. Control Sham) mice, and the μMT mutation itself did not affect thymus weight (Fig. 1b). Weight of the androgen-sensitive seminal vesicles was also similar in μMT and genotype control mice and equally affected by surgery (Fig. 1c), indicating that testosterone production and action was unaffected by the μMT mutation.
Castration reduced body weight, measured both before and after the high-fat diet period (Fig. 2a,b). Further, castration increased weight of inguinal subcutaneous fat and reduced the weight of the mesenteric fat depots as well as the levels of serum triglycerides (Fig. 2c,e). The genotype of the mice did not significantly affect body weight, weights of fat depots or triglyceride levels. Further, genotype did not influence the effect of castration on these variables (Fig. 2a–e). As the main driver of atherosclerosis is cholesterol, we assessed serum cholesterol levels at 16 weeks. However, no significant differences in serum cholesterol levels were detected across the four groups (Fig. 2e).
At the end of the diet period, atherosclerosis was assessed by quantification of atherosclerotic lesion area in serial sections of the aortic root (Fig. 3a). Lesion size integrated over 0–800 μm from the aortic cusps was significantly increased by castration (+ 60.4 ± 14.5% in Control ORX vs. Control Sham and + 42.6 ± 12.2% in μMT ORX vs. μMT Sham) and by the μMT mutation (+ 37.5 ± 11.1% in μMT Sham vs. Control Sham and + 22.3 ± 10.5% in μMT ORX vs. Control ORX) (Fig. 3b), with no significant interaction between genotype and surgery as determined by 2-way ANOVA. Thus, castration-induced atherogenesis was not affected by the μMT mutation.
Discussion
In this study, we utilized μMT mice that lack mature B cells to explore whether B cell deficiency affects the atherogenic response to castration in male mice. Our main finding is that castration evoked a similar increase in atherosclerosis in μMT and littermate control mice. Further, compared to control mice, male μMT mice showed a small increase in atherosclerosis.
The fact that castration evoked a similar atherogenic response in μMT and control mice suggest that there is no direct link between castration-induced increase in mature B cell numbers and castration-induced atherogenesis. Castration and AR deficiency increases numbers of B cell precursors in bone marrow as well as mature B cells in spleen via two distinct mechanisms7,8,9. In further support of B cell-independent castration-induced atherogenesis, both total and oxLDL-specific immunoglobulins were unaltered in serum of AR-deficient mice that have been shown to mirror the castration-induced B cell and atherosclerosis phenotypes4,8,9,12. Mature B cells are deleted in μMT mice as they cannot produce membrane-bound IgM that is needed for their development. In previous studies, neither B cells nor immunoglobulins (total or oxLDL-specific) could be detected in μMT Apoe-/- mice fed a high-fat diet13,14. Spleen weight was reduced by 65% in this μMT setting13, as compared to 76% in our study, supporting the validity of our model. Nevertheless, μMT mice have been reported to have small numbers of innate B cells that escape by using another constant chain than mu when challenged15. Although these B cells are few, we cannot exclude that they might contribute to regulation of atherosclerosis in the μMT/castration model. Of further note, B cell deficiency may theoretically induce changes in plaque characteristics such as plaque composition and macrophage infiltration, and it is a limitation of our study that these variables have not been addressed. However, while castration increases atherosclerotic lesion area, our previous work has shown that it does not evoke changes in relative plaque collagen or macrophage content in the atherosclerosis setting used in the present study4.
Castration also affects T cell homeostasis and we recently showed that castration-induced atherogenesis was blocked by a T cell depletion regimen12. Further, male mice with depletion of the AR specifically in epithelial cells showed increased atherosclerosis that was abolished by prepubertal thymectomy, indicating that the thymic epithelial cell is a target cell for the anti-atherogenic actions of testosterone12. Notably, here the effect of castration on thymus weight was equal in μMT and genotype control mice. Although T and B cells often act in concert, our data indicates that the castration-induced pro-atherogenic effect on thymic epithelial cells and T cells is predominantly B cell-independent. Further studies are needed to decipher how B cell deficiency affects castration-induced changes in T cell response, which is beyond the scope of this study.
In the present study, male μMT mice showed slightly increased atherosclerosis compared to littermate controls. Previous data on atherosclerosis development in μMT mice are scarce and conflicting. In contrast to our data, one study reported a 65% reduction of atherosclerosis in intact μMT Apoe-/- mice16. In the same study, transfer of wild-type B2 cells to μMT Apoe-/- mice increased atherosclerosis16. Lethally irradiated, Ldlr-/- mice injected with bone marrow from μMT donors developed increased atherosclerosis17, suggesting a protective action of bone marrow-derived B cells. Further, the spleen has been suggested to host a protective B cell-mediated response in atherosclerosis18,19. The role of B cells in atherosclerosis is complex and B cells may be both pro- and anti-atherogenic, depending on subset, stage of disease, and effector functions elicited6. Of note, depletion of B cells disrupts the architecture of secondary lymphoid organs including development of certain macrophage populations20, which may play a role. The atherosclerosis phenotype of μMT mice in different experimental conditions will require further study.
In conclusion, we show here that castration evokes a similar atherogenic response in B cell-deficient μMT and control mice. These data suggest that atherogenesis following castration is unrelated to the effects of androgens on mature B cell numbers.
Methods
Animals
μMT mice10, homozygous mutant mice that lack mature B cells (Ighmtm1Cgn, Jackson strain #002,288) were crossed with apolipoprotein E knockout (Apoe-/-) mice (B6.129P2-Apoetm1Unc, Taconic model #APOE). μMTmut/wt Apoe+/- mice were then intercrossed to generate male homozygous mutant mice (μMTmut/mut Apoe-/-) and male littermate genotype control mice (μMTwt/wt Apoe-/-) that were used in this study. Confirmation of gene disruption was screened by polymerase chain reaction genotyping. The strains were backcrossed into a C57BL/6 background for more than 10 generations. Androgen receptor-deficient (Ary/fl Pgk-Cre+ Apoe-/-) males and controls (Ary/+ Pgk-Cre+ Apoe-/-) were generated and genotyped as previously described4,21.
Study protocol
The mice were housed in a temperature- and humidity-controlled room with a 06:00–18:00 h light cycle and consumed diet and tap water ad libitum. The mice consumed a soy-free diet (#2016; Harlan Teklad) after weaning and a high fat diet (#821424, 21% fat from lard, 0.15% cholesterol, Special Diets Services) beginning at 8 weeks of age. At 3 weeks of age, the mice were anesthetized (isoflurane), either sham-operated or bilaterally castrated (orchiectomized). Postoperatively, the mice were given analgesic subcutaneously (buprenorphine) and antibiotics orally (enrofloxacin; added to the drinking water). At 16 weeks of age, the mice were fasted for 3–4 h and euthanized during anesthesia. Blood was drawn from the left ventricle and the circulatory system was perfused with 0.9% saline (pH 7.4) under physiological pressure. Serum was collected from whole blood and frozen for later analysis. Spleen, thymus, seminal vesicles, and fat depots were dissected, and wet weight was recorded. The heart was dissected, and the aortic root was slowly frozen in OCT embedding medium for later processing. All experiments were approved by the Ethics Committee on Animal Care and Use in Gothenburg and followed the Institute for Laboratory Animal Research Guide for the Care and Use of Laboratory Animals as well as the ARRIVE guidelines.
Serum total and oxLDL immunoglobulins
Levels of total and specific IgM and IgG directed against copper oxLDL were determined in thawed serum by chemiluminescent enzyme-linked immunosorbent assay (ELISA) as previously described22,23, and with purified goat anti-mouse IgG (#M30100, Invitrogen) as coating antibody for total IgG. Samples were diluted 1:300 for IgM, 1:50000 for IgG, and 1:200 for oxLDL IgM and IgG. Results were normalized to median levels in the Ary/+ mice and expressed as arbitrary units (AU).
Serum triglycerides and cholesterol
Serum total triglyceride and cholesterol levels were determined using Infinity reagents (TR22421 and TR13421, Thermo Fisher Scientific), according to the manufacturer’s instructions.
Lesion analyses in the aortic root
Serial 10-μm cryosections were cut distally from the aortic root. The sections (0, 200, 400, 600 and 800 µm after the appearance of the aortic cusps) were stained with lipid-reactive Oil Red O and counterstained with hematoxylin. The sections were then evaluated by a blinded observer. We used morphometric analysis (BioPix Software) to determine the area of the atherosclerotic lesions and length of the external elastic lamina (EEL) after manual delineation. As an estimate of atherosclerotic lesion size, atherosclerotic lesion areas were normalized to EEL length and these values were integrated to quantify the total plaque burden.
Statistical analyses
Statistical evaluations were performed using GraphPad prism software (version 8.4.3). Variables were tested for normal distribution by Shapiro–Wilk normality test. All variables passed normality with or without log transformation and were analyzed by 2-way ANOVA with genotype and surgery as independent variables or unpaired T test. P values of < 0.05 were considered statistically significant. Data represent mean ± SEM or median [IQR].
Data availability
The datasets generated during and analyzed during the current study are available from the corresponding author on reasonable request.
References
Kelly, D. M. & Jones, T. H. Testosterone: A vascular hormone in health and disease. J. Endocrinol. 217, R47-71. https://doi.org/10.1530/JOE-12-0582 (2013).
Ohlsson, C. et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J. Am. Coll. Cardiol 58, 1674–1681. https://doi.org/10.1016/j.jacc.2011.07.019 (2011).
Tivesten, A., Pinthus, J. H., Clarke, N., Duivenvoorden, W. & Nilsson, J. Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms. Urol. Oncol. 33, 464–475. https://doi.org/10.1016/j.urolonc.2015.05.030 (2015).
Bourghardt, J. et al. Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology 151, 5428–5437 (2010).
Ketelhuth, D. F. & Hansson, G. K. Adaptive response of T and B cells in atherosclerosis. Circ. Res. 118, 668–678. https://doi.org/10.1161/CIRCRESAHA.115.306427 (2016).
Sage, A. P., Tsiantoulas, D., Binder, C. J. & Mallat, Z. The role of B cells in atherosclerosis. Nat. Rev. Cardiol. 16, 180–196. https://doi.org/10.1038/s41569-018-0106-9 (2019).
Sakiani, S., Olsen, N. J. & Kovacs, W. J. Gonadal steroids and humoral immunity. Nat. Rev. Endocrinol. 9, 56–62. https://doi.org/10.1038/nrendo.2012.206 (2013).
Wilhelmson, A. S. et al. Testosterone is an endogenous regulator of BAFF and splenic B cell number. Nat. Commun. 9, 2067. https://doi.org/10.1038/s41467-018-04408-0 (2018).
Wilhelmson, A. S. et al. Androgens regulate bone marrow B lymphopoiesis in male mice by targeting osteoblast-lineage cells. Endocrinology 156, 1228–1236. https://doi.org/10.1210/en.2014-1822 (2015).
Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423–426. https://doi.org/10.1038/350423a0 (1991).
Porsch, F., Mallat, Z. & Binder, C. J. Humoral immunity in atherosclerosis and myocardial infarction: From B cells to antibodies. Cardiovasc. Res. 117, 2544–2562. https://doi.org/10.1093/cvr/cvab285 (2021).
Wilhelmson, A. S. et al. Testosterone protects against atherosclerosis in male mice by targeting thymic epithelial cells-brief report. Arterioscler. Thromb. Vasc. Biol. 38, 1519–1527. https://doi.org/10.1161/ATVBAHA.118.311252 (2018).
Tay, C. et al. B cell and CD4 T cell interactions promote development of atherosclerosis. Front. Immunol. 10, 3046. https://doi.org/10.3389/fimmu.2019.03046 (2019).
Srikakulapu, P. et al. Chemokine receptor-6 promotes B-1 cell trafficking to perivascular adipose tissue, local IgM production and atheroprotection. Front. Immunol. 12, 636013. https://doi.org/10.3389/fimmu.2021.636013 (2021).
Ghosh, S., Hoselton, S. A. & Schuh, J. M. Mu-chain-deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model. J. Immunol. 189, 1322–1329. https://doi.org/10.4049/jimmunol.1200138 (2012).
Tay, C. et al. B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation. Cardiovasc. Res. 111, 385–397. https://doi.org/10.1093/cvr/cvw186 (2016).
Major, A. S., Fazio, S. & Linton, M. F. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 22, 1892–1898. https://doi.org/10.1161/01.atv.0000039169.47943.ee (2002).
Grasset, E. K. et al. Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response. Proc. Natl. Acad. Sci. USA 112, E2030-2038. https://doi.org/10.1073/pnas.1421227112 (2015).
Caligiuri, G., Nicoletti, A., Poirier, B. & Hansson, G. K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Investig. 109, 745–753. https://doi.org/10.1172/JCI7272 (2002).
Tumanov, A. et al. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity 17, 239–250. https://doi.org/10.1016/s1074-7613(02)00397-7 (2002).
De Gendt, K. et al. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc. Natl. Acad. Sci. USA 101, 1327–1332. https://doi.org/10.1073/pnas.0308114100 (2004).
Chou, M. Y. et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J. Clin. Investig. 119, 1335–1349. https://doi.org/10.1172/JCI36800 (2009).
Jennbacken, K., Stahlman, S., Grahnemo, L., Wiklund, O. & Fogelstrand, L. Glucose impairs B-1 cell function in diabetes. Clin. Exp. Immunol. 174, 129–138. https://doi.org/10.1111/cei.12148 (2013).
Acknowledgements
The authors thank Annelie Carlsson for excellent research assistance. This work was supported by the Swedish Research Council (Grant 2021-01856 to Å.T.), the Swedish Heart-Lung Foundation (Grant 20210492 to Å.T.), the Novo Nordisk Foundation (Grant NNF18OC0034464 to Å.T.) and Grants from the Swedish state under the agreement between the Swedish government and the county councils (the ALF-agreement; ALFGBG-721451 to Å.T.).
Funding
Open access funding provided by University of Gothenburg.
Author information
Authors and Affiliations
Contributions
A.S.W. and Å.T. conceived the study. A.S.W., I.J., L.F., J.B.F., and Å.T. performed experiments and analyzed data. J.F.A. and M.C.I.K. provided conceptual and technical advice. A.S.W., M.C.I.K., and Å.T. wrote the manuscript. All authors reviewed the text.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wilhelmson, A.S., Johansson, I., Fogelstrand, L. et al. Deficiency of mature B cells does not alter the atherogenic response to castration in male mice. Sci Rep 12, 12931 (2022). https://doi.org/10.1038/s41598-022-16846-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-022-16846-4
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.